4 completed, 2 terminated. 2 Not applicable, 2 Phase 2, 1 Phase 1, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 2 | Completed 2 |
| Phase 2 | 2 | Completed 2 |
| Phase 1 | 1 | Terminated 1 |
| Phase 4 | 1 | Terminated 1 |
Follow pentetreotide: new trials by email Literature Review of pentetreotide trials Research Report on pentetreotide
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Somatostatin Receptor Imaging in Patients With Suspected Cardiac Sarcoidosis Indium-111 Pentreotide, Gallium-68 DOTATATE - Sarcoidosis | Not applicable | Completed | Marcelo F. Di Carli, MD, FACC | 17 | 2015-10-01 | 2020-04-09 |
| Comparative Study of Sensitivity of Ga-DOTATOC PET vs Octreoscan SPECT + CT gallium Ga 68-edotreotide, positron emission tomography/computed tomography, indium In 111 pentetreotide - Adult Medulloblastoma, Childhood Medulloblastoma | Phase 2 | Completed | Sue O'Dorisio | 68 | 2013-04-01 | 2021-09-22 |
| Combination Targeted Radiotherapy in Neuroendocrine Tumors 131-I MIBG and 111-In pentetreotide, 131-I MIBG and In-111 DOTATATE - Neuroendocrine Tumors | Not applicable | Completed | David Bushnell | 2 | 2006-09-01 | 2016-07-21 |
| Study to Evaluate the Effect of Age (Geriatric) and Kidney Function on the Safety, Efficacy and Pharmacokinetics of OctreoScan in Patients Who Have New or Recurrent Tumors Indium In-111 pentetreotide - Solid Tumors | Phase 4 | Terminated | Mallinckrodt | 150 | 2003-07-01 | 2016-09-09 |
| New Imaging Techniques in the Evaluation of Patients With Ectopic Cushing Syndrome Pentetreotide, 18F-DOPA, CT scan - Cushing Syndrome, Endocrine Disease | Phase 2 | Completed | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | 95 | 1999-05-20 | 2021-04-14 |
| Indium In 111 Pentetreotide in Treating Patients With Refractory Cancer indium In 111 pentetreotide - Brain and Central Nervous System Tumors, Childhood Langerhans Cell Histiocytosis | Phase 1 | Terminated | Yale University | 35 | 1996-10-01 | 2014-07-02 |
Neoplasms (2) · Neuroendocrine Tumors (2) · Somatostatinoma (2) · Adenoma, Islet Cell (1) · Carcinoma, Islet Cell (1) · Carcinoma, Medullary (1) · Carcinoma, Merkel Cell (1) · Carcinoma, Renal Cell (1) · Central Nervous System Neoplasms (1) · Cushing Syndrome (1) · Endocrine System Diseases (1) · Esthesioneuroblastoma, Olfactory (1) · Gastrinoma (1) · Glucagonoma (1) · Head and Neck Neoplasms (1)
David Bushnell (1) · Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (1) · Mallinckrodt (1) · Marcelo F. Di Carli, MD, FACC (1) · Sue O'Dorisio (1) · Yale University (1)
United States (6)
David Bushnell, M.D. (1) · John R. Murren, MD (1) · Lynnette K Nieman, M.D. (1) · M. Sue O' Dorisio, MD, PhD (1)
P30CA086862 (1), R01CA167632 (1)